ideayabio.com (IDYA) - Dana dhuwit saben siji saham

Lambang korporat lan logo IDEAYA Corp (IDYA)

IDEAYA Biosciences' status as a pioneer in synthetic lethality makes the company a favorite in precision oncology. The cash per share metric visualizes this market optimism, where the 8.74 mark reflects the latest data. Capital growth is based on a unique scientific and technological ecosystem with strong pharma partners and a streamlined, high-speed biomaterial supply chain.

ideayabio.com (IDYA) - Dhuwit awis saben siji saham saka 04.07.2022 nganti 20.11.2026

Rincian metrik komprehensif lan analitis IDEAYA Corp (IDYA)

- rega pasar lan target rega analis:
- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:IDEAYA Bio - IDYA
Barang unggulan IDEAYA Bio

For IDEAYA Biosciences (IDYA), whose development depends on clinical trial success and partner payments, the cash per share metric serves as an indicator of financial autonomy. This metric calculates the portion of liquid assets per share, determining the business's margin of safety and its ability to fund R&D without external borrowing, which is critically important for companies operating outside of macroeconomic cycles.